Search research articles
Contact Us
Filters
Showing results (41-50 of 170) with videos related to
Page
of 17
Sort By:
European Journal of Haematology
|
May 1, 1992
Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia
L Campos, D Guyotat, C Jaffar, et al.
Oncogene
|
April 21, 2001
Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization
N Droin, C Rébé, F Bichat, et al.
International Journal of Cancer
|
July 10, 1999
FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection
N Favre, B Bonnotte, N Droin, et al.
International Journal of Cancer
|
July 1, 1994
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance
E Solary, Y H Ling, R Perez-Soler, et al.
Cancer Gene Therapy
|
July 12, 2008
Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
G Jeudy, F Salvadori, B Chauffert, et al.
The Journal of Biological Chemistry
|
August 8, 2001
Caffeine sensitizes human H358 cell line to p53-mediated apoptosis by inducing mitochondrial translocation and conformational change of BAX protein
L Dubrez, J L Coll, A Hurbin, et al.
Journal of Cellular and Molecular Medicine
|
February 13, 2008
Heat shock proteins: essential proteins for apoptosis regulation
D Lanneau, M Brunet, E Frisan, et al.
Presse Medicale (Paris, France : 1983)
|
December 16, 1987
[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)]
H Guy, D Caillot, E Solary, et al.
Blood
|
April 18, 1998
BCR-ABL delays apoptosis upstream of procaspase-3 activation
L Dubrez, B Eymin, O Sordet, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 9, 2000
Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway
N Favre-Felix, A Fromentin, A Hammann, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 170) with videos related to
Sort By:
Page
of 17
European Journal of Haematology
|
May 1, 1992
Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia
L Campos, D Guyotat, C Jaffar, et al.
Oncogene
|
April 21, 2001
Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization
N Droin, C Rébé, F Bichat, et al.
International Journal of Cancer
|
July 10, 1999
FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection
N Favre, B Bonnotte, N Droin, et al.
International Journal of Cancer
|
July 1, 1994
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance
E Solary, Y H Ling, R Perez-Soler, et al.
Cancer Gene Therapy
|
July 12, 2008
Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
G Jeudy, F Salvadori, B Chauffert, et al.
The Journal of Biological Chemistry
|
August 8, 2001
Caffeine sensitizes human H358 cell line to p53-mediated apoptosis by inducing mitochondrial translocation and conformational change of BAX protein
L Dubrez, J L Coll, A Hurbin, et al.
Journal of Cellular and Molecular Medicine
|
February 13, 2008
Heat shock proteins: essential proteins for apoptosis regulation
D Lanneau, M Brunet, E Frisan, et al.
Presse Medicale (Paris, France : 1983)
|
December 16, 1987
[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)]
H Guy, D Caillot, E Solary, et al.
Blood
|
April 18, 1998
BCR-ABL delays apoptosis upstream of procaspase-3 activation
L Dubrez, B Eymin, O Sordet, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 9, 2000
Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway
N Favre-Felix, A Fromentin, A Hammann, et al.
Page
of 17